Study Design. A family-based study.
L ow back pain (LBP) is the most debilitating disease globally, 1 lumbar disc degeneration (LDD) being one of its major risk factors. 2 Lumbar disc consists of outer annulus fibrosus containing type I and type II collagens and inner nucleus pulposus containing proteoglycans responsible for maintenance of tissue hydration. 3 In classical twin studies, LDD was found to be genetically influenced with heritability estimations ranging from 34% to 74%. 4, 5 In comparison, the heritability estimate for sciatica was 20.8%. 6 LDD is a common phenotype influenced by several genetic and environmental factors. 7 The genetic background of common multifactorial phenotypes is composed of both common and rare genetic components. 8 In many common diseases such as osteoarthritis and osteoporosis, the common alleles typically explain only modest portion of heritability. [9] [10] [11] Thus, it is thought that rare alleles [minor allele frequency (MAF) <0.01] and alleles with low frequency (0.01 < MAF < 0.05) could explain a substantial fraction of the heritability in common diseases. 8 Modic changes (MCs), pathological bone marrow signal changes adjacent to vertebral endplates, represent a distinct specific phenotype of LDD. They are visible only on magnetic resonance imaging (MRI) 12 and have been associated with LBP. 13 
From the
The prevalence of MC in the general population ranges from 22% to 56%. 13 The heritability of MC is estimated to be 16% to 43%.
14 On the basis of candidate gene approach, interleukin 1-a (IL1A) and matrix metalloproteinase 3 (MMP3) polymorphisms may play a role in MC, 15, 16 but so far, no genome-wide association studies or next-generation sequencing have been performed. We have earlier described 14 Finnish families with a history of LDD characterized by sciatica. 17 In order to identify rare predisposing variation behind MC and to find genetic factors contributing to the underlying molecular mechanisms, we performed whole exome sequencing, that is, sequencing of the whole protein coding region of the human genome using high-throughput DNA sequencing methods in two of these families.
MATERIALS AND METHODS
Out of the 14 families with history of LDD characterized by sciatica, 17 two large families with several affected family members in at least two generations were chosen for MRI evaluation and exome sequencing analysis (Figure 1 12, 18 The maximum depth of each MC was graded from all sagittal slices compared with height of the vertebral body as (0) no MC, (1) MC in the endplate, (2) MC less than 25%, (3) MC from 25% to 50%, and (4) MC more than 50% of the height of the vertebral body. The horizontal length was assessed in three zones in the AP direction (anterior, midpoint, and posterior lesions) as described in the study by Mä ä ttä et al. 19 The interobserver reliability was calculated for the presence of MC (kappa ¼ 0.9). In Family I, seven family members had MC, while four were unaffected. In Family II, seven were unaffected. MCs were present in eight family members. MC types, sizes, and locations of the affected family members are presented in Table 1 .
Four affected individuals with MC from Family I and three from Family II and one healthy individual from both families were selected for whole exome sequencing ( Figure 1 ). This study was approved by the Ethics Committee of the Northern Ostrobothnia Hospital District and family members gave their informed written consent.
The whole exome sequence data were acquired through commercial service (BGI, Hong Kong, http://www.bgi.com/), including exome capture, alignment, and allele calling. The exome capture was performed using the SureSelect 51M Capture Kit (Agilent Technologies, Santa Clara, CA, USA), which targets 75 Mb of the human genome with >350,000 exons. The exome targets were sequenced with the IlluminaHiSeq2000 100PE platform (San Diego, CA, USA) and the reads were aligned to the hg19 human reference genome. 
Variant calling was performed using Genome Analysis ToolKit (GATK). 20 Alleles were processed using GATK to filter them according to quality parameters. We filtered out alleles according to threshold values, which were for single nucleotide polymorphisms (SNP): the root mean square of the mapping quality <40, Haplotype score >13, and genotype quality <20, and for small insertions and deletions (indels): quality by depth <2.0, Phred-scaled P value using Fisher exact test >200.0, and the u-based z-approximation from the MannWhitney Rank Sum Test for mapping qualities <À20.0.
Alleles shared by the affected family members were extracted and alleles that were found in the unaffected individuals or in the in-house exome set (N ¼ 71) or had MAF >1% in 1000Genomes database were filtered out. The remaining rare and private alleles were annotated using annotate variation (ANNOVAR) version 2013aug23 21 to identify alleles having harmful pathogenicity estimations (SIFT, PolyPhen-2, MutationTaster) and alleles affecting active promoters or strong enhancer regions (ENCODE databases for chromHMM estimations for HSMM and GM12878 cells) ( Table 2 ). All databases used were downloaded and all annotations were done according to the ANNOVAR manual. The frequency for alleles cosegregating with MC in general Finnish population was obtained from the Sequencing Initiative Suomi (SISu) database (N ¼ 6118) (http://www.sisuproject.fi/) and the Exome Aggregation Consortium (ExAC) (http://exac.broadinstitute.org). MAF in European population was also obtained from the ExAC.
After the annotation, alleles were validated using capillary sequencing with ABI3500xL Genetic Analyzer (Applied Biosystems) from all family members to find alleles cosegregating with MC. 
RESULTS
In each family, only one rare and pathogenic allele cosegregated with MC. The c.4829_4831delAGCinsCACTGTG (NM_005529) allele leads to an insertion and deletion mutation p.Q1611delfsX20 (NP_005520.4) in the heparan sulfate proteoglycan 2 (HSPG2) gene cosegregated with MC in Family I with complete penetrance (Figure 1 ; Table 1 ). This mutation was considered deleterious by MutationTaster (Table 3 ). It locates in the exon 38 encoding the third domain of the protein and alters the open reading frame resulting in a premature termination codon. The allele identified in Family II was a single-nucleotide polymorphism (SNP), c.1657G>A (NM_014757.4) (rs61753465), causing glutamic acid to lysine change p.Glu553Lys (NP_055572.1) in the mastermind-like transcriptional coactivator 1 (MAML1) gene ( Table 2 ). The SNP was estimated to be probably damaging by PolyPhen-2 (Table 3 ) and was found from eight individuals with MC observed in MRI. The SNP was also carried by two unaffected family members aged 27 and 35 years (Figure 1) .
Each identified allele was private to the respective families, meaning that the affected family members with HSPG2 mutation in Family I did not share any rare pathogenic alleles in the MAML1 gene. Similarly, affected members in Family II shared no rare pathogenic alleles in the HSPG2 gene. The exome alignment covered well both gene loci in both families, the average coverage of the exome sequencing being 67x, supporting the findings that these families each have their own allele associating with the disease.
DISCUSSION
We have identified plausible causative or predisposing alleles for MC in two families. First, an insertion and deletion mutation in the HSPG2 gene (p.Q1611delfsX20) that encodes a protein called perlecan with an important role in the structure and function of musculoskeletal tissues. Second, we identified a glutamate to lysine amino acid change (p.Glu553Lys) in the MAML1 gene. MAML1 acts as a transcriptional coactivator in the Notch signaling pathway participating in the joint cartilage maintenance. 22 Perlecan is a heparan sulfate proteoglycan expressed in mammalian cartilage and basement membranes.
23 HSPG2 has 94 exons and the encoded protein consists of five domains. 24 Although some mutations in HSPG2 cause fatal recessive disorders, more subtle alleles can predispose to less severe phenotypes. Rare SNPs in HSPG2 have been associated with another spinal disorder, idiopathic scoliosis (IS). 25 Mutations in HSPG2 also cause rare autosomal recessive disorders, dyssegmental dysplasia Silverman-Handmaker type (DDSH), and Schwarzt-Jampel syndrome (SJS) 26, 27 (Supp. Figure S1 , http://links.lww.com/BRS/B244).
DDSH is a fatal condition characterized by flat facial appearance, narrow thorax, short neck, short and bowed limbs, decreased joint mobility, and atypical ossification centers of the vertebral bodies. 28 SJS is characterized by reduced stature, chondrodysplasia, and skeletal anomalies, including kyphoscoliosis and flattened vertebral bodies. 29 Differences in SJS and DDSH phenotypes are proposed to result from the differences in the amount of functional perlecan in the extracellular matrix. 26, 27 Here, the affected individuals in Family I carried a novel heterozygous mutation p.Q1611delfsX20 in HSPG2 resulting in premature termination codon. Previously, a premature termination codon in perlecan has been shown to result to mRNA instability through nonsense mRNA-mediated decay. 26 Thus, the mutation in HSPG2 (p.Q1611delfsX20) MAML1 forms a complex with intracellular Notch receptors and is considered to be a transcriptional coactivator in the Notch signaling pathway. 30 Notch signaling pathway regulates variety of biological functions including cartilage development and homeostasis. [31] [32] [33] [34] Notch signaling is required during joint cartilage maintenance and loss of notch signaling in postnatal murine joints leads to osteoarthritis. [35] [36] [37] Osteoarthritis is, similarly to disc degeneration, characterized by degeneration of cartilage, joint space narrowing, and formation of osteophytes.
MAML1 has been shown to have several functions independent of notch signaling in a variety of biological processes. [38] [39] [40] Study of maml1 knockout mice showed that the mouse homolog maml1 enhances the transcriptional activity of runx2 in Notch-independent manner. The knockout mice were characterized with impaired chondrocyte maturation. 41 In humans, RUNX2 is a transcription factor essential in the differentiation and proliferation of osteoblasts and chondrocytes. 42 RUNX2 has been reported to be highly expressed in the degenerated discs 43 and is upregulated in discs with MC compared with discs with no MC. 44 On the basis of these studies, we hypothesize that MAML1 could affect the disc structure via notch signaling pathway and/or by affecting RUNX2 activity. The p.Glu553Lys (MAML1) alters the protein structure as glutamic acid is replaced by lysine. Glutamic acid has an acidic and negatively charged side chain, whereas the one in lysine is basic and positively charged. The p.Glu553Lys (MAML1) is present also in two family members unaffected at the time of MRI (year 2014). These individuals were only 27 and 35 years of age at the time, however, and as age has been shown to be a risk factor for MC especially in the lower lumbar spine, 45 ,46 a follow-up MRI of these two individuals is needed to fully confirm the role of this allele.
We acknowledge limitations that may have impacted our study. The sample size was relatively small and the role of these genes needs to be investigated. Each identified allele was private to one single family. This is not unexpected, however, as founder mutations, that is, mutations descending from a single ancestor have been described for example in genes causing familial breast cancer. [47] [48] [49] [50] [51] Chondrocytic cell lines were not available for the predictions of the promoter and enhancer regions. Instead, data from HSMM and GM12878 cell lines were used. The activity of the promoter and enhancer regions can vary between tissues or cell lines, 52 and this may have affected our results. It should also be noted that the presence of the MC (or disc degeneration) does not always correlate with symptoms.
In summary, we have identified two new promising candidate genes for MC: MAML1 and HSPG2. The SNP p.Glu553Lys in the MAML1 gene and the indel p.Q1611delfsX20 in the HSPG2 gene cosegregated with MC in families. These genes have an important role in the maturation and proliferation of chondrocytes. Perlecan is a structural protein in the disc and MAML1 may affect the disc structure through Notch signaling and/or RUNX2 activation. The role of the genes needs to be studied further in other sample sets with data on MC. Our findings are novel in spinal degenerative phenotypes.
Key Points
Whole exome sequencing was carried out for two Finnish families with Modic changes in order to identify rare alleles cosegregating with the phenotype. MAML1 and HSPG2 were identified as novel candidate genes for Modic changes in Finnish families. These genes are important in cartilage structure and joint cartilage maintenance.
